type-2-diabetes

Documents about type-2-diabetes

• Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance#154823ClinicalTrials.gov
• Investigation for Health Efficacy of Infrared-C Radiation on Diabetes Patients in Senior's Activity Center#154833ClinicalTrials.gov
• Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls#158122ClinicalTrials.gov
• Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes#181672ClinicalTrials.gov
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness#184761ClinicalTrials.gov
• ASSOCIATION BETWEEN HbA1C AND TRIGLYCERIDE LEVELS IN DIABETES MELLITUS PATIENTS WITH OBESITY#194589Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)
• Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysis.#148094NCBI PubMed Central
• A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics#136213ClinicalTrials.gov
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients#143749ClinicalTrials.gov
• Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD#172531ClinicalTrials.gov
• Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study#152350ClinicalTrials.gov
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus#158186ClinicalTrials.gov
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)#127815ClinicalTrials.gov
• Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria#127745ClinicalTrials.gov
• An Analytical Study on the Prevalence of Type-2 Diabetes among American Adults#11953DataCite
• An Analytical Study on the Prevalence of Type-2 Diabetes among American Adults#11954DataCite
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes#28550ClinicalTrials.gov
• Diabetes Effects on Long-Term Implant Survival and Success#126006ClinicalTrials.gov
• To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.#127761ClinicalTrials.gov
• Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus#148650ClinicalTrials.gov
• Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets#28557ClinicalTrials.gov
• Sitagliptin Added-on to Insulin Study (0431-051)#28584ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)#121320ClinicalTrials.gov
• Mechanism of SGLT2 Inhibition in the Kidney#123625ClinicalTrials.gov
• Prospective Study of Patients With Hirsutism#123647ClinicalTrials.gov
• Is Carotid Intima-media Thickness Affected by A1C Variability?#126022ClinicalTrials.gov
• Effect of Sitagliptin on Postprandial Lipoprotein Metabolism#126024ClinicalTrials.gov
• Liraglutide Use in Prader-Willi Syndrome#136214ClinicalTrials.gov
• Dose-Range Finding Study for MK0893 (0893-008)#148699ClinicalTrials.gov
• The Interaction Between Metformin and Physical Training#152346ClinicalTrials.gov
• The Poor Responders Study#152572ClinicalTrials.gov
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure#158142ClinicalTrials.gov
• Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects#162398ClinicalTrials.gov
• Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)#180300ClinicalTrials.gov
• Effects of Colesevelam HCl On Bile Acid Kinetics#181697ClinicalTrials.gov
• Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes#125983ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before#127787ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin#160258ClinicalTrials.gov
• DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes#162348ClinicalTrials.gov
• Evaluating GLP-1 Receptor Agonist in the Treatment of Type 2 Diabetes: A Comparison of Medication Efficacy and Cost#183365BYU ScholarsArchive
• Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study#178042HAL (France)
• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)#160263ClinicalTrials.gov
• Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient#143729ClinicalTrials.gov
• A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise#148701ClinicalTrials.gov
• A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)#172522ClinicalTrials.gov
• Multidisciplinary Team Approach: Working Together to Improve Glycemic Control in Hispanic Adults Diabetes#136243ClinicalTrials.gov
• The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes#141193ClinicalTrials.gov
• Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus#148717ClinicalTrials.gov
• Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin#162425ClinicalTrials.gov
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients#136300ClinicalTrials.gov